Analyst Consensus
- Current Price
- 327.24 $
- Target (Low)
- 330.00 $
- Target (Mean)
- 398.83 $
- Target (High)
- 450.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 36
Recommendation Distribution
Recommendation Distribution| Strong Buy | 7 |
|---|
| Buy | 29 |
|---|
| Hold | 3 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 51.7%
- Operating Margin
- 67.3%
- Gross Margin
- 97.8%
- Return on Equity (ROE)
- 60.3%
- Return on Assets (ROA)
- 19.2%
- Revenue Growth
- 17.1%
- Earnings Growth
- 35.5%
- Debt/Equity
- 67.23
- Current Ratio
- 1.09
- Beta
- 0.77
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 12, 2026 | Truist Securities | Buy → Buy |
| Apr 30, 2026 | Macquarie | Outperform → Outperform |
| Apr 29, 2026 | UBS | Buy → Buy |
| Apr 29, 2026 | Oppenheimer | Outperform → Outperform |
| Apr 29, 2026 | Evercore ISI Group | In-Line → In-Line |
| Apr 29, 2026 | Cantor Fitzgerald | Overweight → Overweight |